Angiotensin II is one of the most powerful blood pressure-raising molecules your body produces. It tightens blood vessels, tells your kidneys to hold onto sodium and water, triggers the release of a hormone that further boosts fluid retention, and even makes you feel thirsty. These actions work together through a single system to keep your blood pressure stable when it drops too low, but when angiotensin II stays elevated for too long, it can damage the heart, blood vessels, and kidneys.
How Your Body Makes Angiotensin II
Angiotensin II is the centerpiece of a hormonal chain reaction called the renin-angiotensin-aldosterone system, or RAAS. The process starts when your kidneys detect low blood pressure or reduced blood flow. In response, they release an enzyme called renin into the bloodstream.
Renin clips a protein made by the liver (angiotensinogen) to form angiotensin I, a molecule with no known biological activity on its own. Angiotensin I then travels to the lungs, where another enzyme, called ACE, removes two amino acids from it and converts it into the active form: angiotensin II. From there, angiotensin II circulates through the body and binds to receptors on blood vessels, kidneys, the adrenal glands, and the brain to carry out its effects.
Raising Blood Pressure Through Vasoconstriction
The most immediate effect of angiotensin II is tightening blood vessels. It binds to AT1 receptors on the smooth muscle lining your arteries and triggers those muscle cells to contract. This narrowing of blood vessels increases resistance to blood flow, which directly raises blood pressure. In healthy people at rest, plasma angiotensin II levels typically range from about 5 to 35 picograms per milliliter, enough to help maintain normal vascular tone without pushing pressure too high.
Your body also has a second type of receptor, AT2, that produces the opposite effect. When angiotensin II binds to AT2 receptors, it causes blood vessels to relax slightly. This built-in counterbalance helps fine-tune how much constriction actually occurs. In most situations, though, the AT1-driven tightening effect dominates.
Sodium and Water Retention in the Kidneys
Angiotensin II acts directly on the kidneys to increase how much sodium they reabsorb from urine back into the bloodstream. It does this by activating sodium transporters in the kidney’s filtering tubes, particularly in the proximal tubule, the first stretch of tubing that processes filtered blood. When more sodium is pulled back into the body, water follows it, which expands blood volume and further supports blood pressure.
This kidney effect operates on multiple timescales. Within minutes of an acute rise in angiotensin II, existing sodium transporters get redistributed to work more efficiently. Over days, the kidneys actually increase the total number of these transporters. Interestingly, research in animal models shows the kidneys also have a compensatory mechanism: after about two weeks of sustained angiotensin II exposure, some of the early transporters in the kidney get downregulated. Without this built-in brake, sodium excretion would drop by roughly 21% instead of rising, suggesting the kidneys actively resist holding onto too much sodium when angiotensin II stays high.
Triggering Aldosterone Release
Beyond acting on the kidneys directly, angiotensin II stimulates the adrenal glands (small hormone-producing glands that sit on top of each kidney) to release aldosterone. Specifically, it targets cells in the outer layer of the adrenal cortex. When angiotensin II binds to receptors on these cells, it activates pathways that raise calcium levels inside the cell and switch on the machinery for making aldosterone.
Aldosterone then travels to the kidneys and promotes even more sodium and water retention, amplifying what angiotensin II already started. This two-layer system, angiotensin II acting on the kidneys directly plus aldosterone adding a second wave, is what makes the RAAS so effective at restoring blood pressure after a drop. It also explains why blocking this system is a cornerstone of treating high blood pressure.
Driving Thirst and Fluid Intake
Angiotensin II doesn’t just retain the water already in your body. It also makes you drink more. Researchers first demonstrated this in 1968, when injecting angiotensin into the brain’s hypothalamus produced an immediate and specific drinking response in animal models. The key brain structure involved is the subfornical organ, a small region that sits outside the blood-brain barrier and can detect angiotensin II circulating in the bloodstream.
When blood-borne angiotensin II reaches the subfornical organ, it also stimulates the release of vasopressin (sometimes called antidiuretic hormone), which tells the kidneys to concentrate urine and conserve water. So angiotensin II coordinates fluid balance from multiple angles at once: tightening vessels, retaining sodium, triggering aldosterone, promoting thirst, and reducing water loss through urine.
What Happens When Levels Stay Too High
In the short term, angiotensin II’s effects are protective. They keep blood flowing to vital organs during dehydration, blood loss, or a sudden drop in pressure. Problems arise when the system stays activated chronically, as it does in conditions like uncontrolled high blood pressure, heart failure, or kidney disease.
Prolonged exposure to angiotensin II causes the heart muscle to thicken in a harmful way. Brief activation can produce a form of adaptive growth that maintains or even improves heart function. But over weeks and months, this transitions into pathological thickening. The heart muscle stiffens, scar tissue (fibrosis) develops, and the heart gradually loses its ability to pump efficiently. This progression from adaptive to maladaptive thickening is a well-established risk factor for heart failure.
Chronic angiotensin II also drives inflammation and oxidative stress throughout the vascular system. It promotes the infiltration of immune cells into blood vessel walls and ramps up production of reactive oxygen species, molecules that damage cells and impair the inner lining of blood vessels. This damage reduces the availability of nitric oxide, a molecule that normally keeps vessels relaxed and healthy. The combination of stiffened vessels, chronic inflammation, and impaired vessel lining contributes to long-term cardiovascular damage in conditions like hypertension and diabetes.
How Medications Target This System
Two major drug classes work by limiting angiotensin II’s effects, and they do it at different points in the chain. ACE inhibitors block the enzyme that converts angiotensin I into angiotensin II, reducing how much of it your body produces. ARBs (angiotensin receptor blockers) take a different approach: they let angiotensin II be produced normally but block it from binding to AT1 receptors, preventing most of its blood pressure-raising and tissue-damaging effects.
Both classes are widely prescribed for high blood pressure (generally defined as readings above 140/90 mmHg) and are also used in heart failure and kidney disease to reduce the strain that chronic angiotensin II places on those organs. The choice between them often comes down to side effects and individual tolerance rather than a large difference in effectiveness.